2021
DOI: 10.1155/2021/6677012
|View full text |Cite
|
Sign up to set email alerts
|

Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients

Abstract: Proprotein convertase subtilisin/kexin 9 (PCSK9) plays an important role in lipid metabolism while available literature regarding its involvement in the pathogenesis of atherosclerosis and in the expression of genes associated with apoptosis and inflammation is constantly increasing. Patients with chronic kidney disease (CKD) experience disproportionately increased cardiovascular morbidity and mortality due to dyslipidemia, accelerated atherosclerosis, inflammation, oxidative stress, and other risk factors. In… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 58 publications
(60 reference statements)
1
11
0
Order By: Relevance
“…Although mainly located in the liver PCSK9 is also expressed in vascular smooth muscle and endothelial cells and its expression is increased by stimulation with LPS (55), suggesting a critical role of PCSK9 in vascular function. Plasma PCSK9 levels have been shown to serve as a late biomarker of the severity of illness in patients with severe trauma injury in ICU (56) and sepsis (57) and have been correlated to endothelial dysfunction in patients with chronic kidney disease (58).…”
Section: Discussionmentioning
confidence: 99%
“…Although mainly located in the liver PCSK9 is also expressed in vascular smooth muscle and endothelial cells and its expression is increased by stimulation with LPS (55), suggesting a critical role of PCSK9 in vascular function. Plasma PCSK9 levels have been shown to serve as a late biomarker of the severity of illness in patients with severe trauma injury in ICU (56) and sepsis (57) and have been correlated to endothelial dysfunction in patients with chronic kidney disease (58).…”
Section: Discussionmentioning
confidence: 99%
“…However, being the effect of RYR mainly due to the presence of lovastatin, it is likely that an overexpression of PCSK9 may attenuate the reduction of LDL-C seen in animals treated with RYR. On the other hand, elevation of PCSK9 occurs under conditions of increased oxidative stress and inflammation [ 45 ]. This also explains the better response found with BPF compared to RYR.…”
Section: Discussionmentioning
confidence: 99%
“…Metformin and protamine demonstrate a similar effect, and they are already approved to use in humans to treat diabetes [198,199]. Some suggest utilization of PCSK9, considering their significant pleiotropic effect, but this is just a theory [200]. The potential effect of interfering with that pathway is a suppression of highly atherogenic Lp(a) [200].…”
Section: Therapeutic Implication Of the Post-sepsis Alterations In Lipid Profilementioning
confidence: 99%
“…Some suggest utilization of PCSK9, considering their significant pleiotropic effect, but this is just a theory [200]. The potential effect of interfering with that pathway is a suppression of highly atherogenic Lp(a) [200].…”
Section: Therapeutic Implication Of the Post-sepsis Alterations In Lipid Profilementioning
confidence: 99%